2004 Annual Meeting | Contemporary Clinical Issues and Case Studies Plenary Session
| 09:00 AM - 12:00 PM |
Abstract Presenter: Targeted Fascicular Biopsy of Proximal Nerves with MRI Abnormality may Be Diangostically Informative
P. James B. Dyck, MD, FAAN |
|
| 09:00 AM - 12:00 PM |
Discussant: Targeted Fascicular Biopsy of Proximal Nerves with MRI Abnormality may Be Diangostically Informative
John W. Griffin, MD |
|
| 09:00 AM - 12:00 PM |
Abstract Presenter: Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Nonvalvular Atrial Fibrillation (SPORTIF V)
Gregory W. Albers, MD |
|
| 09:00 AM - 12:00 PM |
Discussant: Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Nonvalvular Atrial Fibrillation (SPORTIF V)
S. C. Johnston, MD, PhD, FAAN |
|
| 09:00 AM - 12:00 PM |
Abstract Presenter: Superiority of Diffusion-Weighted MRI for Depicting the Lesions Related to Creutzfeldt-Jakob Disease
Yusei Shiga |
|
| 09:00 AM - 12:00 PM |
Discussant: Superiority of Diffusion-Weighted MRI for Depicting the Lesions Related to Creutzfeldt-Jakob Disease
James A. Mastrianni, MD, PhD |
|
| 09:00 AM - 12:00 PM |
Multiple Sclerosis: Early Diagnosis and Early Treatment
Stephen L. Hauser, MD |
|
| 09:00 AM - 12:00 PM |
Neuroprotection in Parkinson's Disease: Reality or Myth?
Kathleen M. Shannon, MD, FAAN |
|
| 09:00 AM - 12:00 PM |
Estrogen in Neurologic Disease: Risk or Benefit?
Victor W. Henderson, MD, FAAN |
| Victor W. Henderson, MD, FAAN | Dr. Henderson has stock in Abbott, Amgen, Roche. The institution of Dr. Henderson has received research support from NIH. The institution of Dr. Henderson has received research support from Health IQ. Dr. Henderson has received personal compensation in the range of $500-$4,999 for serving as a External advisory committee member, Alzheimer's Disease Center with University of Kansas. Dr. Henderson has a non-compensated relationship as a adjunct (honorary) professor with Aarhus University that is relevant to AAN interests or activities. |
| Gregory W. Albers, MD | No disclosure on file |
| Kathleen M. Shannon, MD, FAAN | The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. |
| P. James B. Dyck, MD, FAAN | Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis. |
| Stephen L. Hauser, MD | Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities. |
| S. C. Johnston, MD, PhD, FAAN | No disclosure on file |
| John W. Griffin, MD | No disclosure on file |
| Yusei Shiga | No disclosure on file |
| James A. Mastrianni, MD, PhD | Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Mastrianni has received research support from Brain Research Foundation. |